Products and Technologies
Relevant Industrial | January 09, 2024
Relevant Industrial, LLC a leader in value-added distribution and service for instrumentation and automation, rotating equipment, valve, purification, and thermal equipment solutions, announced the acquisition of CHEMFLOW Products and its subsidiaries, CHEMSeal Couplings and ChlorineValves.com (CHEMFLOW).
CHEMFLOW is a leading value-added distributor and manufacturers' representative specializing in precision-engineered Flow Control products for Chemical services. With over 75 years of combined expertise, CHEMFLOW has brought together the highest quality manufacturers of valves, automation, breakaway couplings, safety shutdown systems, and hoses, affording customers specially designed solutions meeting stringent industry standards for hazardous chemical bulk transfer in the safest possible way. CHEMFLOW brings an unmatched expertise in packaging a full range of products and services designed to improve reliability, enhance safety and environmental impact, and minimize downtime.
Relevant Industrial's strategic acquisition of CHEMFLOW Products aligns seamlessly with its commitment to delivering comprehensive and cutting-edge solutions to clients across various industries. This move enhances Relevant Industrial's portfolio, allowing the company to offer a broader range of services and products to its clientele, as well as offer Relevant's unique set of industrial automation solutions to CHEMFLOW's strong customer base.
John Carte, CEO of Relevant Industrial, expressed enthusiasm about the acquisition, stating, "The addition of CHEMFLOW Products to the Relevant Industrial family is a significant step forward in our mission to provide top-tier solutions to our customers. CHEMFLOW's extensive experience and proficiency in Flow Control products for hazardous chemicals complement our capabilities. We are confident that this acquisition will both benefit our customers and contribute to the continued growth and success of Relevant Industrial."
Mike Johnson, CEO of CHEMFLOW Products, shared his perspective on the collaboration, stating, "We are thrilled to join forces with Relevant Industrial. This partnership represents a strategic alignment of values, expertise, and commitment to customer satisfaction. Together, we look forward to delivering innovative solutions and unparalleled value to our customers." As part of this collaboration, Mike will transition to the role of Vice President of Chlor-alkali Business Development within the dynamic CHEMFLOW/Relevant team. In this capacity, he will leverage his extensive industry knowledge and strong leadership skills to lead initiatives aimed at expanding Relevant Industrial's footprint in the chlor-alkali sector.
CHEMFLOW Products and its subsidiaries will become an integral part of Relevant Industrial, contributing to the company's expanded workforce of over 450 employees. The combined entity will operate from a total of 30 strategic locations, further adding to existing customer service capabilities and extending its reach across the majority of the lower 48 states. With an OEM status that provides a global reach, Relevant Industrial is poised to further strengthen its position as an industry leader.
This strategic acquisition is anticipated to create collaborative dynamics that will not only benefit customers, partners, and employees but also propel Relevant Industrial and CHEMFLOW Products into a new era of mutual growth and innovation. The powerful combination of expertise and resources between Relevant Industrial and CHEMFLOW Products opens new horizons for both companies, fostering accelerated customer service, deeper chemical industry capabilities, and enhanced technical expertise.
About CHEMFLOW
CHEMFLOW Products LLC, celebrated for its unwavering commitment to "SOLUTIONS WITH INTEGRITY," functions as a Manufacturers' Representative Company specializing in Flow Control products designed for applications in Chemical services. With a focal point on Hazardous Chemicals, the company exhibits distinct expertise in various domains, including Chlor-akali, AgChem, Vinyls, Urethanes, Refrigerants, Polysilicon, Pigments, and HF Alkylation. A distinguished leader in Flow Control solutions for hazardous chemicals, CHEMFLOW has been a stalwart in serving industries for over 15 years. Their specialization encompasses applications involving Chlorine, Chlor-akali, AgChem, Vinyls, Urethanes, Refrigerants, Polysilicon, Pigments, and HF Alkylation, showcasing unparalleled proficiency in specialty valve applications, safety shutdown systems, bulk transfer hose & coupling, and sampling valves.
About Relevant Industrial
Relevant Industrial, LLC, is a leading value-added distribution channel serving mission-critical applications across diverse industries. Founded in 1965 as Wilson-Mohr, today Relevant is a dynamic partner providing expert solutions in instrumentation and automation, rotating equipment, valves and valve actuation, purification, and thermal equipment. Relevant Industrial brings together the finest problem-solvers in the world: trained technicians, engineers, designers, and experts in a dozen other crafts focused on finding answers and delivering results. We sell parts and services, but our mission goes beyond that; we help customers realize new and better ways to operate more efficiently. Every solution we deliver is specialized and customized for each demanding situation a client presents to us.
Read More
Chemical Technology
Chemify | January 23, 2024
Chemify and Prepaire™ Labs announced to expand their partnership with an additional program to tackle the ongoing Opioid crisis and develop a novel class of digitally discovered non-addictive Opioids as pain modulators, as well as drugs tackling Opioid addiction directly by combining Chemify's breakthrough programmable chemistry platform with Prepaire’s integrated novel open collaboration drug discovery platform. The project, named Toxifree, comes in response to the FDA’s Center for Drug Evaluation and Research (CDER) requesting drugmakers and researchers to develop treatments for stimulant use disorder, hoping to address a major gap in the addiction crisis response.
After a successful initial partnership, Chemify and Prepaire are now aiming to leverage Chemify's Chemputation technology which enables the automated and integrated design, discovery, and synthesis of complex molecules on demand using a chemical programming language and Prepaire's advanced open-architecture drug development platform.
Under the terms of this partnership, Chemify will design and discover novel compounds to identify Opioid-derived hits and develop them further into candidates. Chemify will receive at least USD $30 million in payments and pre-negotiated, success-driven clinical and regulatory milestones for each developed molecule, as well as single digit royalties on any resulting products.
Lee Cronin, Chemify's Founder and CEO and Regius Professor of Chemistry at the University of Glasgow has extensive experience leading research efforts to develop solutions for the opioid crisis. Cronin lead a team that won several NIH-prize challenges including winning the grand runner up prize for the design, discovery and automated synthesis of next generation, safer and non-addictive drug-candidates to help address the opioid crisis.
"We are extremely excited to combine Chemify's technology for molecular design, discovery and synthesis with the integrated Prepaire platform to expand our collaboration and create a fully integrated, digitally driven drug discovery approach. With this partnership we are breaking ground on a new pain modulation discovery program that aims to tackle the global need for better and non-addictive pain medication. With our unique design approach guided by Chemputation, we are utilizing an evolutionary approach to discovering novel compounds to solve this devastating and critical healthcare need," said Professor Lee Cronin, Chemify's Founder and CEO.
"Our partnership with Chemify allows our discovery platform to integrate directly with Chemify's chemical space exploration approach, enabling us to access novel chemical matter that would have otherwise been inaccessible. As we progress our collaboration, we are aiming to build an integrated approach that can be used for many more indications beyond novel pain modulators. There aren't any approved treatments to help address addiction to opioids, whose use has surged in recent years. The purpose of this FDA guidance is to assist in the clinical trial designs for the development of novel drugs to support indications for treatment of moderate to severe cocaine use disorder, treatment of moderate to severe methamphetamine use disorder, or treatment of moderate to severe prescription stimulant use disorder," said Dr Vicent Ribas, Prepaire’s Co-Founder.
About Chemputation
Digital chemistry applies principles of computation to chemistry for programable chemistry and Chemify has developed the underpinning infrastructure to make this possible for chemical discovery and synthesis. Like a computer program, digital chemistry programs can automatically run chemical experiments, make new molecules, and ensure that complex chemical recipes are always accessible and perfectly reproducible. Chemical programs are precise pieces of code that allow fully transparent and reliable operation allowing the implementation of AI and other techniques with full audit and safety.
About Chemify
Based in Glasgow, Chemify is a pioneering company digitizing chemistry to provide world-leading pharmaceutical, biotechnology, and industrial partners access to an exponentially growing space of novel molecules and materials. By leveraging decades of chemistry experience, hardware robotics, and artificial intelligence, Chemify's Chemputation technology enables companies to access an end-to-end workflow for drug discovery, molecule synthesis, and materials discovery. Chemify was founded by CEO Lee Cronin based on conceptual advancements from Cronin's Digital Chemistry Laboratory at the University of Glasgow in Scotland. By building the infrastructure to digitize chemistry, Chemify is reimagining chemical research, discovery and manufacturing to benefit all of humanity by accelerating advances across chemistry with a focus on medicine and functional materials.
About Prepaire Labs
Prepaire Labs is a pioneering healthcare technology company focused on revolutionizing drug discovery and precision medicine. Through the integration of deep learning and biology, Prepaire Labs builds predictive models grounded in genetic, phenotypic, and clinical data. These models form a view to the underlying architecture and biology of diseases. Prepaire Labs utilizes patient-derived induced pluripotent stem cells (iPSCs), genome editing, high-content cellular phenotyping, and machine learning to create in vitro disease models that optimize genetics, cell-type, environment, and multidimensional data collection for increased predictability of human clinical outcomes. A state-of-the-art BSL3 lab is opening in May 2024, located at Masdar City, Abu Dhabi, UAE.
Read More
Chemical Management
3E | January 16, 2024
Headquartered in Luxembourg, ChemChain’s proprietary IP and technology will bring an expanded, innovative approach to further augment 3E’s Supply Chain & Sustainability solution, 3E Exchange. 3E Exchange’s unified supply chain platform helps customers organize their global library of supply chain data and streamline workflows in a scalable and compliant manner. Specifically, 3E leverages its market leading digital product passport and renowned regulatory content capabilities to drive best-in-class supply chain management for its growing list of customers. Together, 3E and ChemChain are united in their mission to accelerate global supply chain transparency and sustainability with a unique combination of technology and regulatory expertise.
“ChemChain and 3E share a vision to create a safer, more sustainable world that protects people, safeguards products, and helps businesses grow,” said Greg Gartland, Chief Executive Officer of 3E. “Together with ChemChain, 3E offers an unmatched combination of global regulatory expertise and a cutting-edge platform that dramatically simplifies transferring information along the value chain in a transparent and secure manner. 3E improves cross-functional engagement across global enterprises, and future-proofs products against ever-changing regulations. We look forward to the continued expansion of our supply chain solutions and empowering our clients to further accelerate their sustainability efforts.”
With 175,000+ supplier relationships across all major geographies, the 3E Exchange platform drives a strong return-on-investment for its customers. Powered by 3E’s market leading regulatory expertise covering over 500,000 chemical substances, 3E Exchange enables superior supply chain management while also advancing companies’ ESG objectives. Continued momentum towards sustainable supply chains has highlighted that preparing for a circular economy should be a critical component of every company’s product strategy.
Pete Girard, Managing Director of Supply Chain and Sustainability at 3E, said “The acquisition of ChemChain illustrates our continued focus on supply chain product innovation and thought leadership. The ChemChain team has incubated a novel and tech-forward approach to drive digital product passport adoption, and we look forward to integrating these technologies into 3E Exchange.”
“The highly scalable digital product passport model offers a single source of truth that underpins sustainable supply chain management, while ensuring maximum protection of company trade secrets” added Lorenzo Zullo, Co-Founder and CEO of ChemChain. “As part of 3E, and leveraging tracked experience in end-to-end supply chain transparency across multiple industries, including textile & clothing, furniture, and detergents, ChemChain will accelerate innovation and position customers for success in the face of a highly complex and dynamic global regulatory landscape.”
ChemChain represents 3E’s fourth acquisition announcement since its separation from Verisk in March 2022.
Shearman & Sterling LLP served as the legal advisor to 3E. Cambrian and Elev8law served as the legal advisors to ChemChain.
About 3E
For more than 35 years the world’s leading companies have trusted 3E to provide the intelligent compliance solutions they need to ensure safety and sustainability. Unmatched Environmental, Health, Safety and Sustainability (EHS&S) and product compliance expertise empowers clients to improve chemical and workplace safety, product safety and stewardship and supply chain transparency. 3E is deeply committed to serving its more than 5,000 customers worldwide, representing a wide variety of industries and including the world’s largest chemical manufacturers, retailers and pharmaceutical companies.
About ChemChain
ChemChain is a trusted, decentralized, and globally accepted infrastructure that enables customers to build, exchange, store, and track chemical-related information along the supply chain. ChemChain’s proprietary architecture, underpinned by blockchain technology, facilitates a scalable and tamper-proof digital product passport environment.
Read More
Chemical Technology
Pall Corporation | January 15, 2024
Pall Corporation, a leading provider of filtration, separation and purification solutions, introduces SepraLYTE™ liquid/gas coalescers, an innovative solution designed to meet the increasing demand for efficient separation of electrolyte aerosols from gas in green hydrogen production processes.
Leveraging advanced separation technology, SepraLYTE coalescers excel in the separation of water or electrolyte aerosols (30% potassium hydroxide solution) from hydrogen, ensuring the purity of hydrogen produced from electrolysis processes. They are highly suitable for a wide range of separation applications where minimal pressure drop is crucial for downstream processes.
"Our new SepraLYTE coalescers represent Pall's commitment to serving our customers in energy transition markets. Pall continues to innovate to address new and challenging customer needs in fast growing markets like green hydrogen," said Greg Sears, Vice President and General Manager of Pall's Fluid Technologies and Asset Protection business unit.
"Pall's coalescers enable our customers to optimize their plant design, maximize the lifetime of their critical equipment and improve overall efficiency, reliability and output," said Sears.
These coalescers feature Pall's proprietary melt blown media technology, which achieves outstanding liquid mist separation with low differential pressure. The compact design incorporates coalescer media that ensures compatibility with various chemical applications. Other key advantages of SepraLYTE liquid/gas coalescers is the ease of maintenance, compact size and waste reduction.
Utilizing SepraLYTE liquid/gas coalescers, customers gain significant advantages over conventional separation products. These advantages include reliable, consistent and verifiable separation performance, high gas flow and liquid removal in a compact cartridge, which allow for smaller systems with low capital, operating, and maintenance costs.
About Pall Corporation
Pall Corporation is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of industries. Pall collaborates with customers to advance health, safety, and environmentally responsible technologies. The Company's engineered products enable process and product innovation and minimize emissions and waste.
Read More